Menu
LivaNova PLC is a global medical technology and innovation company built on nearly five decades of experience and a relentless commitment to provide hope for patients and their families through innovative medical technologies, delivering life-changing improvements for both the Head and Heart. Headquartered in London, LivaNova employs approximately 4,000 employees and has a presence in more than 100 countries for the benefit of patients, healthcare professionals and healthcare systems worldwide.
20 Eastbourne Terrace, London W2 6LG
Phone: 442033250662
www.livanova.com
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its first-quarter 2023 results on Wednesday, May 3, 2023 at 1 p.m. L…
A share of LivaNova PLC (NASDAQ:LIVN) closed at $41.20 per share on Friday, down from $42.77 day before. While LivaNova PLC has underperformed by -3.67%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, LIVN fell by -43.68%, with highs and lows ranging from $88.00 to $41.82, […]
LONDON--(BUSINESS WIRE)-- #advancedcirculatorysupport--LivaNova PLC today announced CEO Damien McDonald will present in a fireside chat at the Barclays Global Healthcare Conference on March 16.
LivaNova (LIVN) rose 2.2% amid some vague takeover speculation following the company''s Q4 results and some amendments for executive compensation in a potential…
https://www.investing.com/news/pro/livanova-plc-now-up-5-on-earlier-rumor-432SI-3012542
https://www.investing.com/news/pro/livanova-plc-ticks-higher-after-executive-award-changes-432SI-3012524
https://www.investing.com/news/pro/livanova-pt-lowered-to-65-at-stifel-432SI-3010981
https://www.investing.com/news/pro/livanova-pt-lowered-to-70-at-piper-sandler-432SI-3010967
LivaNova PLC (NASDAQ:NASDAQ:LIVN) Q4 2022 Results Earnings Conference Call February 22, 2023 8:00 AM ETCompany ParticipantsMatthew Dodds - Senior Vice President, Corporate DevelopmentDamien…
The following slide deck was published by LivaNova PLC in conjunction with their 2022 Q4 earnings call.
LONDON (AP) — LONDON (AP) — LivaNova PLC (LIVN) on Wednesday reported fourth-quarter net income of $1.7 million, after reporting…
LivaNova PLC press release (LIVN): Q4 Non-GAAP EPS of $0.81 beats by $0.08.Revenue of $274.9M (+1.8% Y/Y) beats by $12.74M.LivaNova expects revenue for full-year 2023 to grow between…
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today reported results for the quarter and full year ended December 31, 2022 and issued guidance for 2023. …
LONDON--(BUSINESS WIRE)-- #advancedcirculatorysupport--LivaNova PLC reported results for the quarter and full year ended December 31, 2022 and issued guidance for 2023.
LivaNova provides high-tech medical devices for the benefit of healthcare professionals, patients, and healthcare systems worldwide. See why LIVN stock is a Buy.
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced the start of a limited commercial release for the Essenz Perfusion System*. The release has…
LONDON--(BUSINESS WIRE)-- #advancedcirculatorysupport--LivaNova PLC today announced the start of a limited commercial release in Europe for the Essenz™ Perfusion System.